Encyclopaedia - Finance

There are many factors to consider when searching for new growth stock ideas such as estimate revisions, PEG ratios, and earnings growth.

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

However, it is also important to be on the look-out for potential red flags so you can avoid those big losers that can kill a portfolios

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

return. One such pitfall is a high short interest. What is short interest and how can it be helpful to you?

SHORTING-DEFINED

First of

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ll, it would help to define selling short. Essentially, short selling is the opposite of buying stocks - it's the selling of a security t

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

hat the seller does not own, done so in the hope the price will fall. Basically, it is the reverse of going long or buying a stock with t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

he hopes of selling it at a higher price for a profit. Quite simply, short sellers hope to profit from falling stock prices.

SHORTERS AR

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

SMARTER

Short interest is the total number of shares of a particular stock that have been sold short by investors but have not yet been

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

covered or closed out. If a stock has a high short interest, many investors believe that the stock will fall. The reason you should take

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

notice of high short interests is this: short sellers are almost always much smarter than their long counterparts. Short sellers pay muc

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

closer attention to company balance sheets and are more in tune with the fundamentals. It is usually the institutions with billions of d

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ollars that are responsible for large short interests. These are highly-paid number crunchers that spend hours upon hours analyzing compa

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

nies, so disagree with them at your peril.

DONT BE TEASED BY THE SQUEEZE

One reason many investors speculate in stocks with high short

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ositions is the chance of the short squeeze. A short squeeze occurs when short sellers are scrambling to replace their borrowed stock the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

reby increasing demand and decreasing supply, forcing prices up. Short squeezes tend to occur more often in smaller cap, aggressive growt

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

h stocks, which have a very small float (supply), but large caps are certainly not immune from this situation. Unfortunately, however, th

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

s is a very difficult phenomenon to predict. When it works out, you can make a truckload of money as the stock vaults higher, but these o

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ccurrences are few and far between and usually not worth the risk.

WHY RISK IT?

A high short-interest stock should be approached for bu

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ying with extreme caution but not necessarily avoided at all cost. Short sellers (like all investors) aren't perfect and have been known

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

o be wrong from time to time. However, there are over 11,000 stocks that are publicly traded in the United States, so there is bound to b

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e one that meets your fundamental criteria, which does not have a bulging short interest. The logical question becomes, why take the risk

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.encyclopaedia.org.ua/article/102564/encyclopaedia-Short-Selling.html">Short Selling</a>

BB link (for phorums):
[url=http://www.encyclopaedia.org.ua/article/102564/encyclopaedia-Short-Selling.html]Short Selling[/url]

Estate owners are unhappy with the prices the buyers quote. Buyers are scared to buy an estate at a price higher than its present worth. Mortgage brokers and Realtors are out on the streets searching for new avenues. The once blooming tree has shed all its leaves now. Its old and bare, not a fruit seems to be in sight.

Change is a fact of life and as such, we must either learn to adapt to it or perish. In fact, it is our duty to change, to aspire, to progress, to seek perfection and evolve. Change is natural.

The problem in the corporate team building process namely 'distancing' is predominantly inherent in employees' as well as in the employer's psyche. The corporate houses are spending huge amounts to unite the workforce into an active team. However, how the job is done?

Tags

Links

Encyclopaedia - Short Selling

Related Articles: